FIELD: biotechnology.
SUBSTANCE: invention refers to producing differentiated cells by cell reprogramming. Method involves growth of nonpluripotent or somatic cells in growth medium stimulating growth, wherein selected cells grow with optimal growth rate. Further, nucleic acid(s) or protein(s) corresponding to transcription factors or cell development determinants are overexpressed or introduced, usually present in desired cells and cells cultivated in cell culture medium, where cells grow at a rate which is less than optimal speed, and in presence of agent (stimulant) stimulating differentiation.
EFFECT: methods are proposed to produce and use populations of multipotent and pluripotent cells resistant to diseases and capable of differentiation.
9 cl, 1 dwg, 27 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF OBTAINMENT AND APPLICATION OF MULTIPOTENT CELL POPULATIONS | 2008 |
|
RU2535365C2 |
3'-UTR SEQUENCES FOR RNA STABILIZATION | 2016 |
|
RU2783165C1 |
SEQUENCE 3'-UTR FOR RNA STABILIZATION | 2016 |
|
RU2720934C2 |
MODIFIED IMMUNOREGULATORY ELEMENT AND IMMUNITY CHANGE BY THIS ELEMENT | 2017 |
|
RU2767206C2 |
DEEP GLYCATION END PRODUCTS RECEPTOR MODULATORS AND MODULATION | 2020 |
|
RU2820247C2 |
HSD17B13 OPTIONS AND THEIR APPLICATIONS | 2018 |
|
RU2760851C2 |
COMPOSITIONS AND METHODS FOR INTERNALIZATION OF ENZYMES | 2018 |
|
RU2806021C2 |
IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES | 2019 |
|
RU2824391C2 |
ARTIFICIAL MOLECULES OF NUCLEIC ACID | 2014 |
|
RU2717986C2 |
PROMOTER COMPOSITIONS | 2014 |
|
RU2742435C2 |
Authors
Dates
2020-04-08—Published
2014-10-02—Filed